Cas no 63207-03-4 (1-(Dec-1-yl)piperazine)
1-(Dec-1-yl)piperazine Chemical and Physical Properties
Names and Identifiers
-
- Piperazine, 1-decyl-
- 1-DECYLPIPERAZINE
- 1-Decyl-piperazin
- 1-decyl-piperazine
- 1-n-Decylpiperazine
- N-decylpiperazine
- Piperazine,1-decyl
- 1-(1-decyl)-piperazine
- 63207-03-4
- FS-4195
- UUWUIWUPMVSNGJ-UHFFFAOYSA-N
- MFCD01320898
- AKOS009159481
- Piperazine,1-decyl-
- C14H30N2
- CHEMBL4073249
- A10340
- DTXSID90282353
- SCHEMBL162842
- 1-(n-decyl)piperazine
- DB-054430
- NSC-25545
- NSC25545
- 1-(Dec-1-yl)piperazine
-
- MDL： MFCD01320898
- Inchi： 1S/C14H30N2/c1-2-3-4-5-6-7-8-9-12-16-13-10-15-11-14-16/h15H,2-14H2,1H3
- InChI Key： UUWUIWUPMVSNGJ-UHFFFAOYSA-N
- SMILES： N1(CCNCC1)CCCCCCCCCC
Computed Properties
- Exact Mass: 226.24100
- Monoisotopic Mass: 226.240898965g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 16
- Rotatable Bond Count: 9
- Complexity: 142
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Surface Charge: 0
- Tautomer Count: nothing
- XLogP3: 4.1
- Topological Polar Surface Area: 15.3?2
Experimental Properties
- Color/Form: 。
- Boiling Point: 96 °C
- PSA: 15.27000
- LogP: 3.29900
- Solubility: 。
1-(Dec-1-yl)piperazine Security Information
- Hazard Statement： Irritant
-
Hazardous Material Identification：
1-(Dec-1-yl)piperazine Customs Data
- HS CODE：2933599090
- Customs Data：
China Customs Code:
2933599090Overview:
2933599090. Other compounds with pyrimidine ring in structure(Including other compounds with piperazine ring on the structure. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date
Summary:
2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
1-(Dec-1-yl)piperazine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | D209963-250mg |
1-(Dec-1-yl)piperazine |
63207-03-4 | 250mg |
$ 50.00 | 2022-06-05 | ||
| TRC | D209963-500mg |
1-(Dec-1-yl)piperazine |
63207-03-4 | 500mg |
$ 65.00 | 2022-06-05 | ||
| TRC | D209963-2.5g |
1-(Dec-1-yl)piperazine |
63207-03-4 | 2.5g |
$ 135.00 | 2022-06-05 | ||
| Fluorochem | 008906-1g |
1-n-Decylpiperazine |
63207-03-4 | 98% | 1g |
￡15.00 | 2022-03-01 | |
| Fluorochem | 008906-10g |
1-n-Decylpiperazine |
63207-03-4 | 98% | 10g |
￡105.00 | 2022-03-01 | |
| Fluorochem | 008906-25g |
1-n-Decylpiperazine |
63207-03-4 | 98% | 25g |
￡174.00 | 2022-03-01 | |
| Apollo Scientific | OR6897-2g |
1-(Dec-1-yl)piperazine |
63207-03-4 | 98% | 2g |
￡55.00 | 2023-09-02 | |
| Apollo Scientific | OR6897-10g |
1-(Dec-1-yl)piperazine |
63207-03-4 | 98% | 10g |
￡135.00 | 2023-09-02 | |
| Apollo Scientific | OR6897-25g |
1-(Dec-1-yl)piperazine |
63207-03-4 | 98% | 25g |
￡285.00 | 2025-02-20 | |
| abcr | AB143408-2 g |
1-(n-Decyl)piperazine; 97% |
63207-03-4 | 2g |
€93.50 | 2022-03-25 |
1-(Dec-1-yl)piperazine Related Literature
-
Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
-
Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
-
Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
-
Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
-
Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
Additional information on 1-(Dec-1-yl)piperazine
Recent Advances in the Study of 1-(Dec-1-yl)piperazine (CAS: 63207-03-4) and Its Applications in Chemical Biology and Medicine
1-(Dec-1-yl)piperazine (CAS: 63207-03-4) is a chemical compound that has garnered significant attention in recent years due to its potential applications in chemical biology and pharmaceutical research. This piperazine derivative, characterized by a long alkyl chain, exhibits unique physicochemical properties that make it a promising candidate for various biomedical applications. Recent studies have explored its role in drug delivery systems, antimicrobial agents, and as a scaffold for novel therapeutic compounds.
One of the key areas of research involving 1-(Dec-1-yl)piperazine is its use in the development of antimicrobial agents. A 2023 study published in the *Journal of Medicinal Chemistry* demonstrated that derivatives of this compound exhibit potent activity against a range of Gram-positive and Gram-negative bacteria, including multidrug-resistant strains. The study highlighted the compound's ability to disrupt bacterial cell membranes, suggesting a novel mechanism of action that could circumvent existing resistance pathways.
In addition to its antimicrobial properties, 1-(Dec-1-yl)piperazine has been investigated for its potential in drug delivery systems. A recent preprint on *bioRxiv* reported the synthesis of lipid nanoparticles incorporating this compound, which showed enhanced stability and improved cellular uptake in vitro. These findings could pave the way for more efficient delivery of hydrophobic drugs, particularly in cancer therapy.
Another promising avenue of research involves the use of 1-(Dec-1-yl)piperazine as a scaffold for the design of new psychoactive substances (NPS). A 2022 review in *ACS Chemical Neuroscience* discussed the structural versatility of piperazine derivatives and their implications in central nervous system (CNS) drug development. While this area remains controversial due to regulatory concerns, it underscores the compound's potential in CNS-targeted therapies.
Despite these advancements, challenges remain in the clinical translation of 1-(Dec-1-yl)piperazine-based therapies. Issues such as bioavailability, toxicity, and scalability need to be addressed through further preclinical and clinical studies. However, the compound's unique properties and versatility make it a compelling subject for ongoing research in chemical biology and medicine.
In conclusion, 1-(Dec-1-yl)piperazine (CAS: 63207-03-4) represents a promising compound with diverse applications in antimicrobial therapy, drug delivery, and CNS drug development. Continued research into its mechanisms of action and optimization of its derivatives will be crucial for realizing its full potential in the pharmaceutical industry.
63207-03-4 (1-(Dec-1-yl)piperazine) Related Products
- 115281-17-9(Piperazine,1-methyl-4-pentyl-)
- 17096-75-2(1-(5-AMINOPENTYL)PIPERAZINE)
- 73073-90-2(Piperazine,1,4-dihexyl-)
- 115986-20-4(1-(6-AMINOHEXYL)PIPERAZINE)
- 50866-75-6(1-Pentylpiperazine)
- 51619-55-7(1-Hexylpiperazine)
- 54256-45-0(1-N-Octylpiperazine)
- 166657-94-9(12-(Piperazin-1-yl)dodecan-1-amine)
- 54722-41-7(Piperazine, 1-tetradecyl-)
- 55546-05-9(Piperazine, 1-dodecyl-4-methyl-)
Audited Supplier
Audited Supplier
Audited Supplier
Audited Supplier
Audited Supplier
